Reaction

Glomerular Filtration Rate Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 802 reports · 38 co-occurring drugs

As of the last recalculation, Glomerular Filtration Rate Increased appears in 802 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 76.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methylprednisolone Acetate	23	76.7	76.9
Esomeprazole Magnesium Capsule, Delayed Release	35	65.4	65.6
Esomeprazole Magnesium Delayed Release Capsules	35	65.4	65.6
Esomeprazole Magnesium Dihydrate	35	65.1	65.3
Diphenhydramine Hydrochloride Capsule, Liquid Filled	42	53.8	53.9
Emtricitabine And Tenofovir Alafenamide	20	46.9	47.0
Cetirizine Hydrochloride Allergy	47	42.7	42.8
Cetirizine Hydrochloride Tablets	47	42.7	42.8
Vitamin E	43	37.4	37.5
Dapagliflozin	43	37.4	37.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	14	36.7	36.8
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	24	35.4	35.4
Emtricitabine And Tenofovir Disoproxil Fumarate	57	34.8	34.9
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	11	32.1	32.2
Voclosporin	9	27.2	27.2
Sennosides 8.6 Mg Tablets	19	24.1	24.1
Senna	19	23.9	24.0
Torsemide	29	23.5	23.6
Anastrozole Tablets	19	23.5	23.5
Eplerenone	11	22.6	22.6
Esomeprazole	50	22.2	22.3
Indapamide	15	22.1	22.1
Senna Leaf	19	21.9	21.9
Tapentadol Hydrochloride	26	20.8	20.8
Duloxetine	49	19.4	19.4
Aripiprazole Oral	29	18.8	18.9
Aripiprazole Orally Disintegrating	29	18.8	18.9
Cetirizine	52	18.5	18.5
Insulin Glargine-Yfgn	15	18.1	18.1
Fenofibrate	24	18.1	18.1
Insulin Glulisine	7	18.0	18.0
Efavirenz	7	16.4	16.4
Polatuzumab Vedotin	6	16.1	16.1
Remdesivir	8	15.7	15.7
Empagliflozin	36	14.5	14.5
Tolvaptan	8	14.4	14.4
Rucaparib	3	8.8	8.8
Bosutinib	3	8.7	8.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.